Circulating APLN levels are higher in people with obesity and T2D and inversely associated with insulin sensitivity, suggesting either APLN resistance or increased secretion from adipose tissue (205, 206, 212, 213). Here, APLN is linked to obesity due to melanocortin 4 receptor deficiency.